Daniel Seigneurin

768 total citations
21 papers, 517 citations indexed

About

Daniel Seigneurin is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Daniel Seigneurin has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Daniel Seigneurin's work include Bladder and Urothelial Cancer Treatments (5 papers), Acute Myeloid Leukemia Research (2 papers) and Breast Lesions and Carcinomas (2 papers). Daniel Seigneurin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Acute Myeloid Leukemia Research (2 papers) and Breast Lesions and Carcinomas (2 papers). Daniel Seigneurin collaborates with scholars based in France and Canada. Daniel Seigneurin's co-authors include G Brugal, Philippe Guillaud, Stanislas du Manoir, Emmanuel Camus, Pierre Champelovier, Jean‐Jacques Rambeaud, Dominique Pasquier, Patrick Lévy, Isabelle Pin and Jean‐Louis Pépin and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The Journal of Urology and Thrombosis and Haemostasis.

In The Last Decade

Daniel Seigneurin

20 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Seigneurin France 11 165 135 110 103 102 21 517
Emily M. King United States 11 356 2.2× 73 0.5× 94 0.9× 54 0.5× 45 0.4× 16 589
Futoshi Ishiguro Japan 16 266 1.6× 83 0.6× 194 1.8× 35 0.3× 392 3.8× 26 880
Giovanni Milazzo Italy 13 220 1.3× 299 2.2× 100 0.9× 50 0.5× 64 0.6× 18 910
Tomomi Sakamoto Japan 11 337 2.0× 66 0.5× 238 2.2× 31 0.3× 50 0.5× 22 615
Marta Hergueta‐Redondo Spain 13 438 2.7× 31 0.2× 124 1.1× 60 0.6× 69 0.7× 16 632
Bruce R. Krawisz United States 11 164 1.0× 67 0.5× 86 0.8× 63 0.6× 50 0.5× 19 663
Yichun Yang China 11 320 1.9× 52 0.4× 92 0.8× 53 0.5× 102 1.0× 27 569
Antônio Hugo José Fróes Marques Campos Brazil 16 269 1.6× 91 0.7× 175 1.6× 63 0.6× 56 0.5× 40 599
Bryon Ellis United States 7 247 1.5× 90 0.7× 47 0.4× 39 0.4× 126 1.2× 8 497
Kathrine Woie Norway 16 199 1.2× 88 0.7× 162 1.5× 41 0.4× 83 0.8× 46 710

Countries citing papers authored by Daniel Seigneurin

Since Specialization
Citations

This map shows the geographic impact of Daniel Seigneurin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Seigneurin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Seigneurin more than expected).

Fields of papers citing papers by Daniel Seigneurin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Seigneurin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Seigneurin. The network helps show where Daniel Seigneurin may publish in the future.

Co-authorship network of co-authors of Daniel Seigneurin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Seigneurin. A scholar is included among the top collaborators of Daniel Seigneurin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Seigneurin. Daniel Seigneurin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Champelovier, Pierre, et al.. (2010). Inhibition of c-Jun N-terminal kinase by SP600125: a cDNA microarray analysis.. PubMed. 7(2). 87–92. 5 indexed citations
2.
Borel, Anne‐Laure, R. Boizel, Patrice Faure, et al.. (2008). Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer. European Journal of Endocrinology. 158(5). 691–698. 62 indexed citations
3.
Devouassoux, Gilles, Patrick Lévy, Eliane Rossini, et al.. (2007). Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure–induced airway hyperresponsiveness. Journal of Allergy and Clinical Immunology. 119(3). 597–603. 96 indexed citations
5.
Champelovier, Pierre, et al.. (2006). Resistance to phorbol ester-induced differentiation in human myeloid leukemia cells: A hypothetic role for the mRNA stabilization process. Leukemia Research. 30(11). 1407–1416. 8 indexed citations
6.
Seigneurin, Daniel, et al.. (2005). Intra-serous haematopoiesis.. PubMed. 19(2). 407–15. 2 indexed citations
7.
Collardeau‐Frachon, Sophie, Dominique Pasquier, Isabelle Treilleux, et al.. (2004). Adénocarcinome mammaire avec composante neuroendocrine majoritaire. Annales de Pathologie. 24(3). 278–283. 5 indexed citations
8.
Piaton, Éric, Laurent Daniel, Véronique Verrièle, et al.. (2003). Improved Detection of Urothelial Carcinomas with Fluorescence Immunocytochemistry (uCyt+ Assay) and Urinary Cytology: Results of a French Prospective Multicenter Study. Laboratory Investigation. 83(6). 845–852. 31 indexed citations
9.
Champelovier, Pierre, et al.. (2003). Is interferon gamma one key of metastatic potential increase in human bladder carcinoma?. PubMed. 9(12). 4562–9. 13 indexed citations
10.
Barbier, Magali, et al.. (2002). Modelling of cell proliferation: nuclear versus membrane labelling. Comptes Rendus Biologies. 325(4). 393–400.
12.
Boutonnât, Jean, Véronique Ducros, Claudine Pinel, et al.. (2000). Identification of Amylase Crystalloids in Cystic Lesions of the Parotid Gland. Acta Cytologica. 44(1). 51–56. 11 indexed citations
13.
Mialhe, Agnès, Pierre Champelovier, Véronique Martel, et al.. (2000). EXPRESSION OF E-, P-, N-CADHERINS AND CATENINS IN HUMAN BLADDER CARCINOMA CELL LINES. The Journal of Urology. 164(3 Part 1). 826–835. 43 indexed citations
14.
Boutonnât, Jean, Magali Barbier, Cécile Rousselle, et al.. (1998). Usefulness of PKHs for studying cell proliferation. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 321(11). 901–907. 9 indexed citations
15.
Mialhe, Agnès, et al.. (1997). Expression of Three Cell Adhesion Molecules in Bladder Carcinomas: Correlation with Pathological Features. Analytical Cellular Pathology. 13(3). 125–136. 14 indexed citations
16.
Rambeaud, Jean‐Jacques, et al.. (1997). Limits of Flow‐Cytometry Histogram Analysis Methods to Assess Bladder Tumour Antigen Expression. Analytical Cellular Pathology. 13(1). 39–47. 5 indexed citations
17.
Rambeaud, Jean‐Jacques, et al.. (1993). Flow and image cytometry for DNA analysis in bladder washings: Improved concordance by using internal reference for flow. Cytometry. 14(8). 943–950. 7 indexed citations
18.
Manoir, Stanislas du, Philippe Guillaud, Emmanuel Camus, Daniel Seigneurin, & G Brugal. (1991). Ki‐67 labeling in postmitotic cells defines different Ki‐67 pathways within the 2c compartment. Cytometry. 12(5). 455–463. 84 indexed citations
19.
Cohen, Olivier, G Brugal, Daniel Seigneurin, & Jacques Demongeot. (1988). Image cytometry of estrogen receptors in breast carcinomas. Cytometry. 9(6). 579–587. 20 indexed citations
20.
Seigneurin, Daniel, et al.. (1983). Auer Rods in Refractory Anemia with Excess of Blasts: Presence and Significance. American Journal of Clinical Pathology. 80(3). 359–362. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026